591P Survival and benefit of adjuvant chemotherapy (ACT) by circulating tumor DNA (ctDNA)-based genomic profile and molecular residual disease (MRD) in resectable colorectal oligometastases (CRM): PRECISION, a prospective multicenter study

Autor: Kobayashi, S., Takamoto, T., Shiomi, A., Takahashi, A., Shiozawa, M., Shimizu, Y., Kagawa, Y., Nobuoka, D., Yamauchi, J., Kato, T., Oki, E., Taketomi, A., Takahashi, Y., Natsume, S., Niguma, T., Nakamura, Y.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S428-S429
Databáze: ScienceDirect